Charles River Laboratories | CRL - 净收入



金融业
股票价格
USD
资产
USD 7.73B
现金及等价物
USD 191.83M
销售成本
USD 716.51M
流动资产
USD 1.49B
流动负债
USD 1.09B
债务
USD 2.57B
EBIT
USD 119.9M
EBITDA
USD 229.8M
员工
18.6K
EPS每股收益
USD 2.06
股本和储备
USD 2.9B
销售毛利
USD 279.32M
债务利息支出
USD 26.74M
利息收入
USD -0.3
贷款资金
USD 2.66B
市值
USD 11.59B
净收入
USD -14.84M
营业费用
USD 875.93M
营业利润
USD 119.9M
普通股股本
USD 48.17M
PE价格收益
29.27
税前利润
USD -294.1M
销售收入
USD 995.8M
销售和管理费用
USD 159.42M
股票
USD 359.72M
贸易债权人
USD 133.95M
应收帐款人
USD 700.25M


净收入 更改 日
Agilent USD 339M 34M 2026-03
Align Technology USD 112.77M 22.99M 2026-03
Bio-Rad Laboratories USD 720M 1.06B 2025-12
Bruker USD 3.5M 22.5M 2026-03
Cardinal Health USD 399M 68M 2026-03
Charles River Laboratories USD -14.84M 261.71M 2026-03
Cigna USD 1.65B 420M 2026-03
Concord Medical Services Hldg CNY -27.14M 63.85M 2025-06
CVS Health USD 2.94B 0 2026-03
Danaher USD 870M 159M 2026-06
Dentsply International USD -10M 136M 2026-03
Elevance Health USD 1.46B 301M 2026-06
Humana USD 1.19B 1.98B 2026-03
Illumina USD 134M 200M 2026-03
Incyte USD 303.33M 4.05M 2026-03
IQVIA Holdings USD 274M 240M 2026-03
Laboratory Of America USD 277.8M 113.1M 2026-03
Lakefront Biotherapeutics EUR 14.49M 767.65M 2026-03
Lonza CHF 426M 119M 2025-06
McKesson USD 1.68B 496M 2026-03
Merck EUR 659M 340M 2026-03
Mettler Toledo International USD 169.45M 116.31M 2026-03
Novartis USD 3.26B 108M 2026-06
Pfizer USD 2.69B 4.34B 2026-03
Quest Diagnostics USD 320M 69M 2026-06
Revvity USD 40.72M 57.65M 2026-03
Thermo Fisher Scientific USD 1.74B 85M 2026-06
United Therapeutics USD 274.9M 89.4M 2026-03
UnitedHealth USD 5.48B 796M 2026-06
Veradigm USD -59.82M 74.35M 2022-12
Waters USD -72M 297.21M 2026-03
West Pharmaceutical Services USD 154M 15.2M 2026-06